The Internal Advisory Committee (IAC) assists in the recruitment of new faculty and fellows to the COCVD. IAC members are Dr. Linda Dwoskin, Dr. David Moliterno and Dr. Stephen Wyatt.
Linda Dwoskin, Ph.D. is an Endowed Professor in Pharmaceutical Education at the University of Kentucky College of Pharmacy. She also is Director and Principal Investigator of a National Cooperative Drug Discovery Group (NCDDG) which collaborates with the National Institutes of Health (NIH) to discover novel treatments for tobacco smoking cessation. She received her B.S. (1974) in psychology from Syracuse University, and Ph.D. (1983) from the Department of Pharmacology at the University of Minnesota. She was a postdoctoral fellow in endocrinology at the Oregon Health Science Center and in the Department of Pharmacology at the University of Colorado Health Science Center. Dr. Dwoskin joined the faculty at the University of Kentucky in 1988 as an assistant professor. She currently holds several other academic appointments including: professor, Department of Behavioral Sciences; adjunct faculty, University of Kentucky Graduate Center; associate, University of Kentucky Center on Drug Abuse Translation; associate, Multi-disciplinary Research Center on Drug and Alcohol Abuse; and associate, Center of Membrane Sciences. Dr. Dwoskin's major research focus is drug discovery in neuropharmacology, i.e., the development of novel therapeutic candidates for the treatment of psychostimulant abuse, specifically for nicotine and methamphetamine abuse.
David Moliterno, M.D. is the Chairman of the Department of Internal Medicine at the University of Kentucky. Dr. Moliterno is the Jefferson M. Gill Professor of Cardiology, the Vice-Chairman of the Department of Internal Medicine, and the Medical Director of the Gill Heart Institute at the University of Kentucky. Dr. Moliterno is an interventional cardiologist, with a nationally prominent research program focused on anti-platelet agents in the treatment of acute coronary syndromes. Dr. Moliterno has published >150 papers with clinical trial results that directly relate to coronary artery disease, cardiac arrhythmias, and thrombolysis. Through his role as Chief of Cardiology, Dr. Moliterno has trained many residents and fellows, and is well suited to provide input to the COCVD investigators and to assist in translating findings to clinical practice. In addition, Dr. Moliterno has been actively recruiting physicians and physician scientists to the Division of Cardiology, and will interface with the Program Director in recruitment of investigators with interests in obesity and cardiovascular disease.
Stephen W. Wyatt, DMD, MPH is the founding Dean of the College of Public Health at the University of Kentucky. He began serving as Dean in November 2004, following six years of research, teaching and service at UK, while serving as the Associate Director for Cancer Control at the Markey Cancer Center. During his tenure at UK, Dr. Wyatt was the PI for several large cancer control grants, including the NCI-funded, Appalachia Cancer Network and Cancer Information Service and the CDC-funded, Prevention Research Center and Comprehensive Cancer Control. During his career, he has experienced public health at the local, regional and national levels, with assignments to the National Health Service Corps, Bureau of Prisons, Health Resources and Services Administration, and the Centers for Disease Control and Prevention. During his tenure at CDC, Dr. Wyatt served as Director of the Division of Cancer Prevention and Control and as Acting Deputy Director of the National Center for Chronic Disease Prevention and Health Promotion. From 2007-2013, he has represented the Association of Schools of Public Health on the Council on Education for Public Health (CEPH), the accrediting body for public health schools/programs, and is serving his fourth term as President of CEPH. Dr. Wyatt’s research interests include: cancer prevention & control, chronic disease prevention, and health promotion.